Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Long-term follow-up after hip surgery with FH ORTHO implants

Official title: Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices (FH ORTHO Company Hip Observatory).

Run by Fh Ortho · NCT05966220 · Data updated 2026-11-12

This follow-up will collect real-world safety and performance data on FH ORTHO hip implants in adults who receive them.

More Hip Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment800 (estimated)
SponsorFh Ortho
Industry-sponsored
Locations5 sites (Guilherand-Granges and 4 other locations)
StatusRecruiting
StartedJanuary 8, 2024
Main results expectedDecember 2038
Study endsDecember 2038
Registry record updatedFebruary 2, 2026
Trial IDNCT05966220 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18 years and older) who receive or have received FH ORTHO hip implants at participating centers and can provide informed consent are eligible candidates.

Probably not a fit

Patients with active or latent infection, known severe bone insufficiency, certain neuromuscular or mental disorders that increase prosthetic risk, or known allergy to device materials are excluded or unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This post-market clinical follow-up (PMCF) observatory gathers clinical data from adult patients receiving FH ORTHO devices for hip arthroplasty or trauma repair at participating centers. A dynamic cohort design allows new inclusions during the enrollment period and replacements for premature exits to maintain follow-up. Surgeons will record device models, implant combinations, and perioperative details in electronic case report forms, while clinical outcomes and complications are captured during routine visits. The registry aims to cover different device versions and combinations to monitor safety, performance, and residual risks under normal use and to meet local regulatory requirements.

Why it matters

Potential benefit: If successful, this effort could improve knowledge of long-term safety and performance of FH ORTHO hip implants and help detect device-related problems earlier.

How similar studies have gone: Similar post-market registries for hip implants have often provided useful safety signals and performance information, although results vary by device and study design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO Company for hip arthroplasty and traumatology, used in accordance with their approved Instruction For Use, in one of the centers participating in the Observatory.
2. Patient is at least 18 years of age.
3. Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally).
4. In some countries, such as France, the patient will have to be socially insured to be included in the study.

Exclusion Criteria:

1. An infection, or latent infection.
2. A mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, failure of prosthetic fixation, or post-operative complications (except for the HIP\&GO Double mobility cemented cup and, if applicable, the associated stems and heads when assembled together).
3. Known Insufficient bone quality and/or bone stock.
4. Known allergy to any component of the material listed on the product label.
5. Metabolic diseases that could compromise bone regrowth.
6. Metabolic and/or vascular treatment or disease that may compromise bone healing or consolidation.
7. Drug dependency.
8. Uncooperative patient unable to follow recommendations.
9. Protected adult

Where it's running

  • Clinique Pasteur
    Guilherand-Granges, France
    Recruiting
  • Centre Hospitalier Du Haut Bugey
    Oyonnax, France
    Recruiting
  • Polyclinique Reims-Courlancy
    Reims, France
    Recruiting
  • Clinique Mutualiste La Sagesse
    Rennes, France
    Recruiting
  • Clinique de l'Atlantique
    Saint-Herblain, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.